Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514473, A61K 3134

Patent

active

056079672

ABSTRACT:
Use of the novel receptor NER TOFA (5-(tetradecyloxy)-2-furan-carboxylic acid) to treat Alzheimer's disease.

REFERENCES:
patent: 4981784 (1991-01-01), Evans et al.
Arbeeny, "Inhibition of fatty acid synthesis decreases renal low density lipoprotein secretion in the hamster", J. Lipid Res. 33: 843-851 (1992).
Ribeneau-Gyon and Gilles, FEBS Lett. 62: 309-312 (1976).
Halvorson and McCune, "Inhibition of fatty acid synthesis in isolated adipocytes by 5-(tetradecyloxy)-2-furoric acid", Lipids 19(11): 851-856 (1984).
Otto et al., "Reciprocal effects of 5-(tetradecyloxy)-2-fuoric acid on fatty acid oxidation", Arch. Biochem. Biophys. 242(1): 23-31, (1985).
Parker et al., "5-(tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids", J. Med. Chem. 20: 781-791 (1977).
Davis et al., "Transcriptional activation by Nur77, a growth factor inducible member of the steroid hormone receptor superfamily" Mol. Endocriniol. 5(6): 854-859, 1991.
Olson, "Reparative strategies in brain-treatment strategies based on trophic factors and cell transfer techniques", Acta Neurochirurgica 58: 3-7, 1993.
Seiger et al., "Intercranial infusion of purified nerve growth factor to an alzheimer patient" Behaviorial Brain Research 57:255-261, 1993.
Power, et al., "Dopamine activation of an orphan of the steroid receptor superfamily", Science 254, pp. 1546-1548, 1991.
Power et al., "New Insights into activation of the steroid hormone receptor superfamily", Trends Pharmacol. Sci. 13(8): 318-323, 1992.
Power et al., "Dopaminergic and igand-independent activation of steroid hormone receptors", Science 254; 1636-1639, 1991.
Lomax and Daniel, "Cocaine and body temperature in the rat: effect of dopamine D1 antagonists", Proc. west Pharmacol. Soc. 34:5-9, 1991.
Witkin et al. "Interaction of haloperidol and SCH23390 with cocaine and dopamine receptor subtype-selective agonists on schedule-controlled behavior of squirrel monkeys", Psychopharmacology Berl. 104(4):452-431, 1991.
Virno et al., "Dopamine, dopaminergic drugs and ocular hypertension", Int. Ophthalmol 16(4-5) 349-353, 1992.
Boyson and Alexander, "Net Production of cerebrospinal fluid is decreased by SCH22390", Ann. Neurol. 27(6): 631-635, 1990.
Lee and Kerlavage, "Molecular biology of G-protein-coupled receptors", Drug News Perspec. 6(7): 488-497, 1993.
Stryer and Bourne, "G proteins, a family of signal transducers", Ann. Rev. Cell. Biol. 2: 391-419, 1986.
Chao et al., "Gene Transfer and Molecular Cloning of the Human NGF Receptor" Science 232: 518-521, 1986.
Levi-Montalcini and Calissano, "The Nerve-Growth Factor" Sci. Amer. 240(6): 68-77. 1979.
Gilman, "G Proteins: Transducers of Receptor-Generated Signals" Ann. Rev. Bichem. 56: 615-49, 1987.
McGurk et al. "Dopaminergic Drugs Reverse the Impairment of Radiol-Arm Maze Performance Caused by Lesions Involving the Cholinergic Medial Pathway", Neuroscience vol. 50, No. 1 pp. 129-135 (1992).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2146285

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.